about
The role of dendritic cells in immunity against primary herpes simplex virus infectionsAn attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeNeuro-Immune Interactions at Barrier SurfacesUps and downs in the search for a Herpes simplex virus vaccine.Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection.Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy.Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface.CD301b+ dendritic cells stimulate tissue-resident memory CD8+ T cells to protect against genital HSV-2.Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.Animal models of herpes simplex virus immunity and pathogenesis.A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques.Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner.Transcriptional Analysis of the Guinea Pig Mucosal Immune Response to Intravaginal Infection with Herpes Simplex Virus Type 2.
P2860
Q26827217-98B3BBE6-1B5E-46AE-BFEF-C2ABD64D4DD3Q33916162-5F752F6E-0CDD-4A8D-A24D-96C4D05514CBQ34525502-2EF6E2B0-05D8-4687-BC71-F1EE0C0614F3Q35160668-1BC3310E-C77A-498D-87E0-F3A9A14B7B99Q35544431-0AEFC418-0668-4F21-A5DF-873ED7EACC71Q35808178-CE2FD5E6-465D-4261-89EE-D83497604563Q36978334-05883754-91B5-44C2-8031-B09F7431B5B6Q37281753-23335970-0ED4-4715-A6C6-DF06A69358AFQ37408667-F906DE67-3CB0-47CA-9ED8-B8C9E480D97CQ37531713-78021A75-5F63-4768-AF15-A521543CB084Q38157833-E10D6A6A-349A-4C5A-8AB0-A36A8AF5F6EDQ38267269-F35685C8-CF1E-4D2A-AABB-00BF3BF19149Q40067153-C6464FA6-C688-4445-B26B-8B463D13F978Q40106495-ADD9BC6A-6AB6-41E1-810A-9566098A641EQ47563232-83A44603-173B-4003-B11B-56FC96989323Q52597757-0AAB645C-EF9A-4DBB-8921-8A66D3BDF813Q53697093-B071B868-D8C2-4BC1-9195-BE983D13D5E3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Generating protective immunity against genital herpes
@en
Generating protective immunity against genital herpes.
@nl
type
label
Generating protective immunity against genital herpes
@en
Generating protective immunity against genital herpes.
@nl
prefLabel
Generating protective immunity against genital herpes
@en
Generating protective immunity against genital herpes.
@nl
P2860
P356
P1433
P1476
Generating protective immunity against genital herpes
@en
P2093
Akiko Iwasaki
P2860
P304
P356
10.1016/J.IT.2013.08.001
P50
P577
2013-09-03T00:00:00Z